The Johns Hopkins Bloomberg School of Public Health will host an expert briefing for the media to discuss trends in tobacco use, the implications of new graphic warning requirements for cigarette packages and ads, and concerns involving products like nicotine pouches and e-cigarettes.
CytomX, Amgen pass on T cell engager; Molecular Partners ends work with Novartis
Plus, news about Atea Pharmaceuticals: CytomX, Amgen stop work on T cell engager: The partners decided to end development of an … Sign up to